Interferon-gamma-release assay prevents unnecessary tuberculosis therapy.
Isr Med Assoc J
; 17(4): 223-6, 2015 Apr.
Article
em En
| MEDLINE
| ID: mdl-26040047
ABSTRACT
BACKGROUND:
The mass influx of immigrants from tuberculosis-endemic countries into Israel was followed by a considerable increase in the incidence of tuberculosis (TB). All contacts of active TB patients are obliged to be screened by tuberculin skin tests (TST) and, if found positive, prophylactic treatment is considered.OBJECTIVES:
To assess the utility of interferon-gamma (IFNγ)-release assay with a prolonged follow-up in preventing unnecessary anti-TB therapy in individuals with suspected false positive results.METHODS:
Between 2008 and 2012 the QuantiFERON TB gold-in-tube test (QFT-G) was performed in 278 sequential individuals who were mostly TST-positive and/or were in contact with an active TB patient. In all, whole blood was examined by the IFNγ-release assay. We correlated the TST diameter with the QFT-G assay and followed those patients with a negative assay.RESULTS:
The QFT-G test was positive in only 72 (42%) of all 171 TST-positive individuals. There was no correlation between the diameter of TST and QFT-G positivity. Follow-up over 5 years was available in 128 (62%) of all QFT-G-negative individuals. All remained well and none developed active TB.CONCLUSIONS:
A negative QFT-G test may obviate the need for anti-TB therapy in more than half of those with a positive TST.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Tuberculose
/
Procedimentos Desnecessários
/
Tratamento Farmacológico
/
Testes de Liberação de Interferon-gama
/
Antituberculosos
Tipo de estudo:
Diagnostic_studies
/
Incidence_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Female
/
Humans
/
Male
País/Região como assunto:
Asia
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article